Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain

Matthieu Lecuyer (1, 2) , Marina Rubio (3) , Clément Chollat (4, 2) , Maryline Lecointre (2, 1) , Sylvie Jégou (2, 1) , Philippe Leroux (2, 1) , Carine Cleren (1, 2) , Isabelle Leroux-Nicollet (2, 1) , Loïc Marpeau (5) , Denis Vivien (6) , Stéphane Marret (2, 1) , Bruno J. Gonzalez (1, 2)

1 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques
2 Neovasc - Team 4 NeoVasc - Region Team ERI 28 INSERM
3 CI-NAPS - UMR 6232 - Centre-Imagerie, Neurosciences, et Application aux Pathologies
4 AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris]
5 Service de Gynécologie-Obstétrique et Médecine de la Reproduction [CHU Caen]
6 Cyceron - GIP Cyceron

Domains: Life Sciences [q-bio]

Matthieu Lecuyer, Marina Rubio, Clément Chollat, Maryline Lecointre, Sylvie Jégou, et al.. Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain. Pharmacology Research & Perspectives, 2017, 5 (4), pp.e00315. ⟨10.1002/prp2.315⟩. ⟨hal-02445361⟩